The First Korean Case of Mucopolysaccharidosis IIIC (Sanfilippo Syndrome Type C) Confirmed by Biochemical and Molecular Investigation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Mucopolysaccharidosis (MPS) III has 4 enzymatically distinct forms (A, B, C, and D), and MPS IIIC, also known as Sanfilippo C syndrome, is an autosomal recessive lysosomal storage disease caused by a deficiency of heparan acetyl-CoA:alpha-glucosaminide N-acetyltransferase (HGSNAT). Here, we report a case of MPS IIIC that was confirmed by molecular genetic analysis. The patient was a 2-yr-old girl presenting with skeletal deformity, hepatomegaly, and delayed motor development. Urinary excretion of glycosaminoglycan (GAG) was markedly elevated (984.4 mg GAG/g creatinine) compared with the age-specific reference range (<175 mg GAG/g creatinine), and a strong band of heparan sulfate was recognized on performing thin layer chromatography. HGSNAT enzyme activity in leukocytes was 0.7 nmol/17 hr/mg protein, which was significantly lower than the reference range (8.6-32 nmol/17 hr/mg protein). PCR and direct sequencing of the HGSNAT gene showed 2 mutations: c.234+1G>A (IVS2+1G>A) and c.1150C>T (p.Arg384*). To the best of our knowledge, this is the first case of MPS IIIC to be confirmed by clinical, biochemical, and molecular genetic findings in Korea.
Abstract
Mucopolysaccharidosis (MPS) III has 4 enzymatically distinct forms (A, B, C, and D), and MPS IIIC, also known as Sanfilippo C syndrome, is an autosomal recessive lysosomal storage disease caused by a deficiency of heparan acetyl-CoA:alpha-glucosaminide N-acetyltransferase (HGSNAT). Here, we report a case of MPS IIIC that was confirmed by molecular genetic analysis. The patient was a 2-yr-old girl presenting with skeletal deformity, hepatomegaly, and delayed motor development. Urinary excretion of glycosaminoglycan (GAG) was markedly elevated (984.4 mg GAG/g creatinine) compared with the age-specific reference range (<175 mg GAG/g creatinine), and a strong band of heparan sulfate was recognized on performing thin layer chromatography. HGSNAT enzyme activity in leukocytes was 0.7 nmol/17 hr/mg protein, which was significantly lower than the reference range (8.6-32 nmol/17 hr/mg protein). PCR and direct sequencing of the HGSNAT gene showed 2 mutations: c.234+1G>A (IVS2+1G>A) and c.1150C>T (p.Arg384*). To the best of our knowledge, this is the first case of MPS IIIC to be confirmed by clinical, biochemical, and molecular genetic findings in Korea.
참고문헌 (22)
- Blau N, "Physician’s guide to the laboratory diagnosis of metabolic diseases. 2nd ed", pp.377~380 (2003), Springer
- Poorthuis BJ, "The frequency of lysosomal storage diseases in The Netherlands", Hum Genet, 105, pp.151~156 (1999)
- Malm G, "Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence", Acta Paediatr, 97, pp.1577~1581 (2008)
- Pinto R, "Prevalence of lysosomal storage diseases in Portugal", Eur J Hum Genet, 12, pp.87~92 (2004)
- Meikle PJ, "Prevalence of lysosomal storage disorders", JAMA, 281, pp.249~254 (1999)
- Lin HY, "Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004", Am J Med Genet A, 149A, pp.960~964 (2009)
- Valstar MJ, "Sanfilippo syndrome: a mini-review", J Inherit Metab Dis, 31, pp.240~252 (2008)
- Berger-Plantinga EG, "Adult-onset dementia and retinitis pigmentosa due to mucopolysaccharidosis III-C in two sisters", J Neurol, 251, pp.479~481 (2004)
- Fan X, "Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C)", Am J Hum Genet, 79, pp.738~744 (2006)
- Hrebícek M, "Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome)", Am J Hum Genet, 79, pp.807~819 (2006)
- Kim CH, "Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations", Hum Mutat, 21, pp.449~450 (2003)
- Sohn YB, "A Mother and Daughter With the p.R443X Mutation of Mucopolysaccharidosis Type II: Genotype and Phenotype Analysis", AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 152A(12), pp.3129~3132 (2010), WILEY-LISS
- Kwon JY, "High prevalence of carpal tunnel syndrome in children with mucopolysaccharidosis type II (Hunter syndrome)", Am J Med Genet A, 155A, pp.1329~1335 (2011)
- Sohn YB, "Retrospective Analysis of the Clinical Manifestations and Survival of Korean Patients With Mucopolysaccharidosis Type II: Emphasis on the Cardiovascular Complication and Mortality Cases", AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 158A(1), pp.90~96 (2012), WILEY-BLACKWELL
- Sohn YB, "Identification of 11 novel mutations in 49 Korean patients with mucopolysaccharidosis type II", CLINICAL GENETICS, 81(2), pp.185~190 (2012), WILEY-BLACKWELL
- 손우연, "Clinical and Laboratory Features of Korean Mucopolysaccharidoses (MPSs)", Korean Journal of Pediatrics, 48(10), pp.1132~1138 (2005), 대한소아과학회
- Voznyi YaV, "A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease C (MPS III C)", J Inherit Metab Dis, 16, pp.465~472 (1993)
- Ruijter GJ, "Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands", Mol Genet Metab, 93, pp.104~111 (2008)
- Feldhammer M, "Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene", Hum Mutat, 30, pp.918~925 (2009)
- Canals I, "Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles", Clin Genet, 80, pp.367~374 (2011)
- Fedele AO, "Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Mutation in brief #959. Online", Hum Mutat, 28, pp.523~ (2007)
- Mühlemann O, "Recognition and elimination of nonsense mRNA", Biochim Biophys Acta, 1779, pp.538~549 (2008)